Vertex Pharmaceuticals Incorporated (LON:0QZU)
London
· Delayed Price · Currency is GBP · Price in USD 490.24
+0.10 (0.02%)
At close: Apr 17, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 95.31 billion as of April 24, 2025. Its market cap has increased by 15.40% in one year.
Market Cap
95.31B
Enterprise Value
88.17B
Revenue
8.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
490.24
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 51.21M to 95.31B, an increase of 186,005.02%. That is a compound annual growth rate of 24.97%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 156.99B |
| GSK plc | 54.15B |
| Haleon | 34.34B |
| Smith & Nephew | 8.61B |
| ConvaTec Group | 5.18B |
| Hikma Pharmaceuticals | 4.16B |
| HUTCHMED (China) | 1.81B |
| Oxford Nanopore Technologies | 1.13B |